Close Menu

skin cancer

NEW YORK (GenomeWeb News) – Verisante Technology said this week that it has begun submitting an application to the US Food and Drug Administration for 510(k) clearance of its Aura skin cancer detection device.

NEW YORK (GenomeWeb) – EKF Diagnostics Holdings today said it and Massachusetts General Hospital have entered into a two-year research collaboration to develop EFK's PointMan assays for certain cancers.

NEW YORK (GenomeWeb) – Biocartis today announced it has obtained CE-IVD marking for and commercially launched the Idylla molecular diagnostics platform and BRAF Mutation Test.

NEW YORK (GenomeWeb News) – Verisante Technology last week posted a sharp drop in Q1 2014 revenues, as the firm terminated its Canadian distributor agreement for its Raman spectroscopy-based Aura skin cancer detection device, choosing instead to pursue a direct sales approach.

NEW YORK (GenomeWeb) – Melanoma test development firm DermTech International has filed to go public with a proposed offering of up to $25 million in stock.

Verisante Technology last week reported second quarter revenues of C$178,000 ($170,000), all from sales of its Aura skin cancer detection device.

Verisante Technology said this week it has signed an exclusive distribution deal with Pacifica Handels to distribute its Aura skin cancer detection device in Switzerland.

Verisante Technology said this week that it has received the first orders for its Raman spectroscopy-based Aura skin cancer detection system and plans an initial production run of 10 devices to be placed in Canada and Europe.

Researchers from the British Columbia Cancer Agency this week presented results from a clinical study in which Verisante Technology's Raman spectroscopy-based Core device distinguished between cancerous and benign lung lesions with sensitivity and specificity of more than 90 perc

Pages

23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.

China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.

In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.

NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.